FDA Adverse Event Malfunction Summary report: N

CADD

MDR report key: 9919225 · Received April 2, 2020

Report

Report Number
3012307300-2020-02481
Event Type
Malfunction
Date Received
April 2, 2020
Date of Event
March 3, 2020
Report Date
December 11, 2020
Manufacturer
ST PAUL
Product Code
FPA
UDI-DI
10610586027536
PMA / PMN Number
K040636
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION COMPLETED ON A SMITHS MEDICAL AMBULATORY INFUSION PUMPS/CADD ADMINISTRATION SETS - FLOW STOP. THE SAMPLE WAS TESTED FOR LEAKING USING HYDROSTAT. THIS WAS CONFIRMED AND OBSERVED FLEEING FROM THE AIR VENT OF THE FILTER. ROOT CAUSE IN ORDER TO PERFORM A COMPLETE ROOT CAUSE ANALYSIS OF THIS FAILURE MODE, CAPA-000542 WAS OPEN ON 30-APR-2019, ON WHICH ROOT CAUSE STATES FILTER LEAKAGE IS CAUSED SILICON OIL TRANSFERRED FROM THE SYRINGES AND/OR VIALS INTO MEDICATION RESERVOIR DURING THE FILLING PROCESS BY THE CUSTOMER. ACTION TAKEN: BY THE DATE THAT IS INVESTIGATION REPORT IS DOCUMENTED, THIS CAPA-000542 WAS CLOSED ON 23-JUL-2020 AND THE CORRECTIVE ACTION INCLUDED ON THIS INVESTIGATION WAS REMOVED FROM THE SCOPE AND INCLUDED IN PROJECT (B)(4), THAT IT WILL ADDRESS THIS REPORTED TO INCLUDE ADDITIONAL IFU VERBIAGE TO INFORM CUSTOMER OF THE PRODUCTS THAT SHOULD NOT BE USED WHEN TRANSFERRING FLUID TO THE MEDICATION CASSETTES. THE PROJECT INFORMATION REFERENCE CAN BE FOUND IN (B)(4).

Additional Manufacturer Narrative · 0

OTHER, OTHER TEXT: INVESTIGATION COMPLETED ON A SMITHS MEDICAL AMBULATORY INFUSION PUMPS/CADD ADMINISTRATION SETS - FLOW STOP . THE SAMPLE WAS TESTED FOR LEAKING USING HYDROSTAT. THIS WAS CONFIRMED AND OBSERVED FLEEING FROM THE AIR VENT OF THE FILTER. ROOT CAUSE IN ORDER TO PERFORM A COMPLETE ROOT CAUSE ANALYSIS OF THIS FAILURE MODE, CAPA-000542 WAS OPEN ON (B)(6) 2019, ON WHICH ROOT CAUSE STATES FILTER LEAKAGE IS CAUSED SILICON OIL TRANSFERRED FROM THE SYRINGES AND/OR VIALS INTO MEDICATION RESERVOIR DURING THE FILLING PROCESS BY THE CUSTOMER. ACTION TAKEN BY THE DATE THAT IS INVESTIGATION REPORT IS DOCUMENTED, THIS CAPA-000542 WAS CLOSED ON (B)(6) 2020 AND THE CORRECTIVE ACTION INCLUDED ON THIS INVESTIGATION WAS REMOVED FROM THE SCOPE AND INCLUDED IN PROJECT 100034, THAT IT WILL ADDRESS THIS REPORTED TO INCLUDE ADDITIONAL IFU VERBIAGE TO INFORM CUSTOMER OF THE PRODUCTS THAT SHOULD NOT BE USED WHEN TRANSFERRING FLUID TO THE MEDICATION CASSETTES. THE PROJECT INFORMATION REFERENCE CAN BE FOUND IN (B)(4).

Additional Manufacturer Narrative · 0

OTHER, OTHER TEXT: INVESTIGATION COMPLETED ON A SMITHS MEDICAL AMBULATORY INFUSION PUMPS/CADD ADMINISTRATION SETS - FLOW STOP . THE SAMPLE WAS TESTED FOR LEAKING USING HYDROSTAT. THIS WAS CONFIRMED AND OBSERVED FLEEING FROM THE AIR VENT OF THE FILTER. ROOT CAUSE IN ORDER TO PERFORM A COMPLETE ROOT CAUSE ANALYSIS OF THIS FAILURE MODE, CAPA-000542 WAS OPEN ON (B)(6) 2019, ON WHICH ROOT CAUSE STATES FILTER LEAKAGE IS CAUSED SILICON OIL TRANSFERRED FROM THE SYRINGES AND/OR VIALS INTO MEDICATION RESERVOIR DURING THE FILLING PROCESS BY THE CUSTOMER. ACTION TAKEN BY THE DATE THAT IS INVESTIGATION REPORT IS DOCUMENTED, THIS CAPA-000542 WAS CLOSED ON (B)(6) 2020 AND THE CORRECTIVE ACTION INCLUDED ON THIS INVESTIGATION WAS REMOVED FROM THE SCOPE AND INCLUDED IN PROJECT 100034, THAT IT WILL ADDRESS THIS REPORTED TO INCLUDE ADDITIONAL IFU VERBIAGE TO INFORM CUSTOMER OF THE PRODUCTS THAT SHOULD NOT BE USED WHEN TRANSFERRING FLUID TO THE MEDICATION CASSETTES. THE PROJECT INFORMATION REFERENCE CAN BE FOUND IN (B)(4).

Description of Event or Problem · 0

INVESTIGATION COMPLETED.

Description of Event or Problem · 0

INVESTIGATION COMPLETED AND SUMMARY IN H 10.

Description of Event or Problem · 0

INVESTIGATION COMPLETED AND SUMMARY IN H 10.

Additional Manufacturer Narrative · 1

REPORT SOURCE: SINGAPORE.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED THAT A NURSE DISCOVERED A POTENTIAL LEAK ON SMITHS MEDICAL CADD ADMINISTRATION SET AT THE IN-LINE FILTER SITE OF THE 0.22 MICRON CADD ADMINISTRATION SET THE GAUZE USED TO WRAP THE SET IS SOAKED WITH CHEMOTHERAPY DRUGS. THE PUMP SETTING WAS 500ML/24HRS. DRUGS USED ARE ETOPOSIDE/DOXORUBICIN/ZINCIRSTINE. THE REPORTED EVENT OCCURRED WHILE IN USE WITH A PATIENT DURING REMOVAL/END OF THERAPY. THERE WAS NO REPORTED PATIENT INJURY. "INFUSION WAS FOR CHEMOTHERAPY THAT IS TREATING A LIFE THREATENING ILLNESS, BUT NOT STRICTLY LIFE SUSTAINING AS IF IT WAS A VASOPRESSOR. PATIENT RETURNED AFTER THE COMPLETION OF THE PUMP. WE ASSUME ANY LEAKS FROM THIS SITE WAS OF NEGLIGIBLE VOLUME AND NOT IMPACTFUL OF THE PATIENT'S TREATMENT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
378360 CADD CADD ADMINISTRATION SETS FPA ST PAUL 21-7394-24 3860307 10610586027536

Patients

Seq Age Sex Outcome Treatment
1